Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death

FASEB Journal

Volumn 24, Issue 8, 2010, Pages 2631-2640

  Himer, Leonóra ^a   Csóka, Balázs ^b   Selmeczy, Zsolt ^a   Koscsó, Balázs ^a   Pócza, Tímea ^a   Pacher, Pál ^c   Németh, Zoltán H ^b,d   Deitch, Edwin A ^b   Vizi, E Sylvester ^a   Cronstein, Bruce N ^e   Haskó, György ^b,f  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d MORRISTOWN MEMORIAL HOSPITAL   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Anergy; Apoptosis; Inflammation

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2A RECEPTOR; CASPASE 3; CASPASE 8; CYCLIC AMP DEPENDENT PROTEIN KINASE; EARLY GROWTH RESPONSE FACTOR 1; EARLY GROWTH RESPONSE FACTOR 3; FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLSERINE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR NFAT; PROTECTIVE AGENT;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATTENUATION; CD4+ T LYMPHOCYTE; CELL DEATH; CELL MEMBRANE; CONTROLLED STUDY; CROSS LINKING; DOWN REGULATION; EXPOSURE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYBRIDOMA; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ANIMAL; CYTOLOGY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL DEATH; FAS LIGAND PROTEIN; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; PROTECTIVE AGENTS; RECEPTOR, ADENOSINE A2A;

EID: 77955814235     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-155192     Document Type: Article

References (63)

1. Krammer, P. H., Arnold, R., and Lavrik, I. N. (2007) Life and death in peripheral T cells. Nat. Rev. Immunol. 7, 532-542
2. Zhang, J., Xu, X., and Liu, Y. (2004) Activation-induced cell death in T cells and autoimmunity. Cell. Mol. Immunol. 1, 186-192
3. Green, D. R., Droin, N., and Pinkoski, M. (2003) Activation-induced cell death in T cells. Immunol. Rev. 193, 70-81
4. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317
5. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., and Nagata, S. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976 (Pubitemid 24106378)
6. Hasko, G., and Cronstein, B. N. (2004) Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25, 33-39 (Pubitemid 38032805)
7. Hasko, G., Linden, J., Cronstein, B., and Pacher, P. (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 7, 759-770
8. Sitkovsky, M. V., Lukashev, D., Apasov, S., Kojima, H., Koshiba, M., Caldwell, C., Ohta, A., and Thiel, M. (2004) Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22, 657-682 (Pubitemid 38680437)
9. Sitkovsky, M. V. (2009) T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response. Trends Immunol. 30, 102-108
10. Linden, J. (2001) Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41, 775-787 (Pubitemid 32385906)
11. Bours, M. J., Swennen, E. L., Di Virgilio, F., Cronstein, B. N., and Dagnelie, P. C. (2006) Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112, 358-404 (Pubitemid 44486409)
12. 2A purinergic receptor-mediated signaling in murine T cells. J. Biol. Chem. 272, 25881-25889
13. Gessi, S., Varani, K., Merighi, S., Ongini, E., and Borea, P. A. (2000) A2A adenosine receptors in human peripheral blood cells. Br. J. Pharmacol. 129, 2-11 (Pubitemid 30072665)
14. + T cells. J. Immunol. 174, 1073-1080
15. 2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Blood 105, 4707-4714
16. 2A receptor activation inhibits T helper 1and T helper 2 cell development and effector function. FASEB J. 22, 3491-3499
17. Huang, S., Apasov, S., Koshiba, M., and Sitkovsky, M. (1997) Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90, 1600-1610 (Pubitemid 27355433)
18. 2A adenosine receptors in the T cell-mediated regulation of colitis. J. Immunol. 177, 2765-2769
19. Sevigny, C. P., Li, L., Awad, A. S., Huang, L., McDuffie, M., Linden, J., Lobo, P. I., and Okusa, M. D. (2007) Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J. Immunol. 178, 4240-4249 (Pubitemid 46492374)
20. 2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111, 251-259
21. Lukashev, D. E., Smith, P. T., Caldwell, C. C., Ohta, A., Apasov, S. G., and Sitkovsky, M. V. (2003) Analysis of A2a receptordeficient mice reveals no significant compensatory increases in the expression of A2b, A1, and A3 adenosine receptors in lymphoid organs. Biochem. Pharmacol. 65, 2081-2090 (Pubitemid 36629591)
22. Jacobson, K. A., Hoffmann, C., Cattabeni, F., and Abbracchio, M. P. (1999) Adenosine-induced cell death: evidence for receptor- mediated signalling. Apoptosis 4, 197-211 (Pubitemid 29378788)
23. Barbieri, D., Abbracchio, M. P., Salvioli, S., Monti, D., Cossarizza, A., Ceruti, S., Brambilla, R., Cattabeni, F., Jacobson, K. A., and Franceschi, C. (1998) Apoptosis by 2-chloro-2′-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells. Neurochem. Int. 32, 493-504 (Pubitemid 28287203)
24. Seto, S., Carrera, C. J., Kubota, M., Wasson, D. B., and Carson, D. A. (1985) Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J. Clin. Invest. 75, 377-383 (Pubitemid 15143475)
25. Kizaki, H., Shimada, H., Ohsaka, F., and Sakurada, T. (1988) Adenosine, deoxyadenosine, and deoxyguanosine induce DNA cleavage in mouse thymocytes. J. Immunol. 141, 1652-1657
26. 2+-mediated mechanisms. Biochem. J. 304 (Pt. 3), 877-885
27. 2A receptor independent effects of extracellular adenosine on murine thymocytes in conditions of adenosine deaminase deficiency. Blood 95, 3859-3867
28. 2A receptor-unrelated lymphotoxicity. Br. J. Pharmacol. 131, 43-50
29. 2A receptor-mediated cell death of mouse thymocytes involves adenylate cyclase and Bim and is negatively regulated by Nur77. Eur. J. Immunol. 36, 1559-1571
30. Nemeth, Z. H., Bleich, D., Csoka, B., Pacher, P., Mabley, J. G., Himer, L., Vizi, E. S., Deitch, E. A., Szabo, C., Cronstein, B. N., and Hasko, G. (2007) Adenosine receptor activation ameliorates type 1 diabetes. FASEB J. 21, 2379-2388 (Pubitemid 47230668)
31. Abe, K., and Matsuki, N. (2000) Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT. Neurosci. Res. 38, 325-329 (Pubitemid 32063338)
32. Hasko, G., Kuhel, D. G., Chen, J. F., Schwarzschild, M. A., Deitch, E. A., Mabley, J. G., Marton, A., and Szabo, C. (2000) Adenosine inhibits IL-12 and TNF-α production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 14, 2065-2074
33. Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P., and Revillard, J. P. (1998) Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J. Clin. Invest. 102, 322-328 (Pubitemid 28335191)
34. Li-Weber, M., Weigand, M. A., Giaisi, M., Suss, D., Treiber, M. K., Baumann, S., Ritsou, E., Breitkreutz, R., and Krammer, P. H. (2002) Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death. J. Clin. Invest. 110, 681-690 (Pubitemid 34988792)
35. Li-Weber, M., Giaisi, M., Baumann, S., Treiber, M. K., and Krammer, P. H. (2002) The anti-inflammatory sesquiterpene lactone parthenolide suppresses CD95-mediated activation-induced-cell-death in T-cells. Cell Death Differ. 9, 1256-1265 (Pubitemid 35331773)
36. Wesselborg, S., Janssen, O., and Kabelitz, D. (1993) Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150, 4338-4345 (Pubitemid 23133710)
37. Shi, Y. F., Szalay, M. G., Paskar, L., Sahai, B. M., Boyer, M., Singh, B., and Green, D. R. (1990) Activation-induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation. J. Immunol. 144, 3326-3333
38. Ashwell, J. D., Cunningham, R. E., Noguchi, P. D., and Hernandez, D. (1987) Cell growth cycle block of T cell hybridomas upon activation with antigen. J. Exp. Med. 165, 173-194
39. Yang, Y., Mercep, M., Ware, C. F., and Ashwell, J. D. (1995) Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181, 1673-1682
40. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., and Green, D. R. (1995) Cell-autonomous Fas (CD95)/ Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441-444
41. Ishimaru, N., Yanagi, K., Ogawa, K., Suda, T., Saito, I., and Hayashi, Y. (2001) Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjögren's syndrome. J. Immunol. 167, 6031-6037
42. Seino, K., Kayagaki, N., Takeda, K., Fukao, K., Okumura, K., and Yagita, H. (1997) Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 113, 1315-1322
43. Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., and Green, D. R. (1998) DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol. Cell 1, 543-551
44. Kasibhatla, S., Genestier, L., and Green, D. R. (1999) Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor κB. J. Biol. Chem. 274, 987-992
45. Norian, L. A., Latinis, K. M., and Koretzky, G. A. (1998) A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes. J. Immunol. 161, 1078-1082
46. Li-Weber, M., Laur, O., Hekele, A., Coy, J., Walczak, H., and Krammer, P. H. (1998) A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation. Eur. J. Immunol. 28, 2373-2383
47. Latinis, K. M., Norian, L. A., Eliason, S. L., and Koretzky, G. A. (1997) Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 272, 31427-31434
48. Li-Weber, M., Laur, O., and Krammer, P. H. (1999) Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation. Eur. J. Immunol. 29, 3017-3027
49. Mittelstadt, P. R., and Ashwell, J. D. (1998) Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression. Mol. Cell. Biol. 18, 3744-3751
50. Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K. N., and Linden, J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527-552
51. + T lymphocytes by adenosine-protein kinase A type I signaling. Cancer Res. 67, 5949-5956
52. Scheibner, K. A., Boodoo, S., Collins, S., Black, K. E., Chan-Li, Y., Zarek, P., Powell, J. D., and Horton, M. R. (2009) The adenosine a2a receptor inhibits matrix-induced inflammation in a novel fashion. Am. J. Respir. Cell Mol. Biol. 40, 251-259
53. Shi, Y., Glynn, J. M., Guilbert, L. J., Cotter, T. G., Bissonnette, R. P., and Green, D. R. (1992) Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257, 212-214
54. Delgado, M., and Ganea, D. (2001) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-κB, NF-AT, and early growth factors 2/3. J. Immunol. 166, 1028-1040
55. Delgado, M., and Ganea, D. (2000) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expression. J. Immunol. 165, 114-123 (Pubitemid 30429498)
56. Minguet, S., Huber, M., Rosenkranz, L., Schamel, W. W., Reth, M., and Brummer, T. (2005) Adenosine and cAMP are potent inhibitors of the NF-κB pathway downstream of immunoreceptors. Eur. J. Immunol. 35, 31-41
57. Nemeth, Z. H., Leibovich, S. J., Deitch, E. A., Vizi, E. S., Szabo, C., and Hasko, G. (2003) cDNA microarray analysis reveals a nuclear factor-κB-independent regulation of macrophage function by adenosine. J. Pharmacol. Exp. Ther. 306, 1042-1049
58. Hasko, G., Szabo, C., Nemeth, Z. H., Kvetan, V., Pastores, S. M., and Vizi, E. S. (1996) Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production inRAW264.7 macrophages and in endotoxemic mice. J. Immunol. 157, 4634-4640
59. 2A receptors. Am. J. Pathol. 163, 711-721
60. Bshesh, K., Zhao, B., Spight, D., Biaggioni, I., Feokistov, I., Denenberg, A., Wong, H. R., and Shanley, T. P. (2002) The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J. Leukoc. Biol. 72, 1027-1036
61. Apasov, S. G., and Sitkovsky, M. V. (1999) The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase. Int. Immunol. 11, 179-189
62. Apasov, S. G., Blackburn, M. R., Kellems, R. E., Smith, P. T., and Sitkovsky, M. V. (2001) Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling. J. Clin. Invest. 108, 131-141
63. + effector T cells by stimulation in the presence of cyclic adenosine 5′-monophosphate-elevating agents. J. Immunol. 169, 1159-1167